Is Oscar Health Stock Still a Buy?

Wall Street thinks health insurance is boring. That's exactly why Oscar Health (OSCR 16.51%) could be your best contrarian play in 2025.This digital-first insurer delivered its first profitable year in 2024 and continued that momentum with exceptional Q1 2025 results: $275 million in net income on $3 billion in revenue, with 42% year-over-year growth. The stock has surged 40% year to date, yet analysts remain skeptical, maintaining lukewarm price targets around $18 -- below where the stock trades ($19.40) ...